December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

231.46 +2.54 (+1.11%)
Streaming Delayed Price Updated: 11:16 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
News headline image
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. 
Via Benzinga
Topics Government
News headline image
Why Danaher (DHR) Stock Is Trading Up Today
Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence... 
Via StockStory
Topics Artificial Intelligence Government
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session. 
Via Chartmill
News headline image
How Do Investors Really Feel About Danaher? ↗
 
Via Benzinga
News headline image
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
News headline image
What's going on in today's session: S&P500 movers ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
3 Reasons to Sell DHR and 1 Stock to Buy Instead
Over the last six months, Danaher’s shares have sunk to $186.35, producing a disappointing 9.1% loss - a stark contrast to the S&P 500’s 18.6% gain. This may have investors wondering how to approach... 
Via StockStory
Topics Stocks
News headline image
Quantum Leap: DTU Breakthroughs Propel Photonic Computing and Graphene Biosensors to the Forefront
In a week poised to redefine the landscape of advanced technology, the Technical University of Denmark (DTU) has unveiled two monumental advancements set to send ripples through the financial markets... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
A Look Into Danaher Inc's Price Over Earnings ↗
In the current market session, Danaher Inc. (NYSE: DHR) price is at $183.36, after a 1.05% spike. However, over the past month, the stock fell by 10.91%, and in the past year, by 34.05%. 
Via Benzinga
News headline image
Danaher Corp (NYSE:DHR) Passes the Caviar Cruise Quality Investment Screen ↗
Danaher Corp (DHR) excels as a quality investment, showing strong revenue growth, a high 38.86% ROIC, solid financial health, and excellent cash flow conversion. 
Via Chartmill
News headline image
Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign... 
Via Benzinga
Topics Economy Government Supply Chain
News headline image
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
DANAHER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
The Unsettling Normalization: Yield Curve's Un-Inversion Signals Potential Storm Ahead
In a development that has sent ripples of concern through financial markets, the U.S. Treasury yield curve underwent a significant un-inversion in April 2025, following its longest inversion in... 
Via MarketMinute
Topics Bonds Economy
News headline image
Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Danaher (NYSE:DHR) and the rest... 
Via StockStory
Topics Economy
News headline image
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
News headline image
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point ↗
RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and alignment with sector valuations. 
Via Benzinga
News headline image
DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
3 Low-Volatility Stocks We Keep Off Our Radar
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Dan Loeb's Third Point Bets Big On AI, Tech With $442 Million Nvidia Stake—Exits Energy, Steel In Q2 Portfolio Overhaul ↗
Third Point's Q2 2025 13F: $442M NVIDIA stake, new tech bets like Meta, exits energy & steel. Full portfolio overhaul details. 
Via Benzinga
Topics Artificial Intelligence
News headline image
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Danaher Corp (NYSE:DHR) Passes the Caviar Cruise Quality Investment Screen ↗
Danaher Corp (DHR) exemplifies the Caviar Cruise investment model with strong sales & EBIT growth, a stellar 38.86% ROIC, and robust cash flow conversion, signaling high quality and operational... 
Via Chartmill
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
iA Global Buys the Dip in Danaher's Stock Price ↗
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.